Bill Schu

A common treatment for traumatic brain injury (TBI) can cause noteworthy adverse effects, so researchers analyzed if the benefits outweigh the potential risks.

The causes and pathogenesis of schizophrenia are still poorly understood, but new research aimed to find answers by looking at childhood milestones.

Science and medicine have licked some of the nastiest afflictions the world has ever seen. But if a child has eczema, should he or she drink milk? The answer is still unknown.

As the population ages and medicine continues to advance, people are living longer and healthier; but they are also taking more medications for more medical conditions. Those medications can cause drug-drug interactions that lead to adverse drug reactions (ADR). Studies have shown that the majority of medication errors happen at the stage of prescription.

With public health concerns surrounding opioid use, a recent study looked at the potential for the opioid analgesic buprenorphine to counteract some of these concerns.

A recent study examined the systemic nature of gout with the goal of identifying proteomic pathways that could lead to co-morbidities in gout patients.

Despite a number of effective medication therapy options, there is international evidence that gout is inadequately treated. Studies in the United States, the United Kingdom, and now Australia, show the same triad of ineffectiveness: low levels of urate-lowering therapy (ULT), infrequent serum urate and renal function testing, and very low rates of achievement of target serum urate levels.

Hepatitis C medication development pipeline still strong, with several additional drugs poised for approval.

Advances in genomic study are enabling researchers to narrow down the specific alleles that may contribute most heavily to the epigenetic reasons behind giant cell arteritis and other rheumatic conditions.

Researchers who looked at the potential association between post-diagnosis opioid use and breast cancer recurrence found no clinically relevant evidence of an association between opioid prescriptions and breast cancer recurrence.

Researchers in Brazil recently noted that marijuana use may mitigate some of the more severe psychiatric side effects associated with crack cocaine addiction, potentially making it easier for addicts to stop using the drug.

The understanding of the inflammatory processes contributing to rheumatoid arthritis continues to grow, leading to greater understanding of RA and improved diagnostic tools and medications.

Our understanding of the genetic mutations in melanoma is growing, but sometimes the more we learn, the more we realize we have yet to learn.

Because there are many types of dementia, with many potential underlying causes, diagnosing it properly can be challenging. Two commonly used tests can return negative results for patients who have demonstrated abnormal cognitive test results or unexplained cognitive dysfunction.

Researchers are still trying to establish a sound definition of bladder pain syndrome, identify its pathophysiology, and suggest a treatment approach that moves beyond specialist care to more individualized treatment.

A recent study looked at the role that family members can play in supporting those with chronic musculoskeletal pain to remain at work, including some novel insights into how effective and important this encouragement can be.

Among dermatologic conditions, necrotizing fasciitis (NF)-a potentially life-threatening infection of the skin and fascia-is notorious and nefarious. While it is not common in developed countries, NF has a high prevalence in undeveloped countries. Immediate treatment is essential, and thus, so is immediate and accurate diagnosis.

A recent study looked at the safety and efficacy of prolonged-release forms of two common opioids-oxycodone and naloxone-in treating chronic pain and opioid-induced constipation, which affects in as many as 40% of opioid-treated patients.

Study shows that adalimumab led to sustained clinical and functional responses in nearly one-third of treatment-refractory patients who completed 10 years of treatment. Patients with shorter disease duration achieved better outcomes, highlighting the need for early treatment.

An increasing number of patients worldwide with severe pemphigus vulgaris (PV) are showing little or no response with conventional steroid treatment; however, a new treatment may become an option.

A recently completed Phase III trial – called PREEMPT – established the efficacy and safety of onabotulinumtoxinA (marketed by Allergan under the brand name Botox®) in treating chronic migraine. Following those results, a new long-term trial is currently underway to analyze some of the clinical questions raised but not answered in PREEMPT.

The skin disease scabies is like the television show Grey's Anatomy: It's been around forever, and you may, every now and again, find yourself wondering, "Is that thing still around?" In both cases, unfortunately, the answer is a definitive "yes."

Studies have shown that major depressive disorder (MDD) has a strong link to genetic factors, and many clinicians and researchers believe the same to be true for obesity.

A recent review looked at the immunopathogenesis of psoriasis, identified key mediators of psoriatic plaques that are being targeted by new and emerging biologic therapies, and highlighted the latest efficacy and safety data from trials of these new agents.

Evidence continues to emerge that biologics-in combination with DMARDS-offer a solid line of defense for patients with rheumatoid arthritis at risk of rapid disease progression .

Compared with the general population, patients with atopic dermatitis are significantly more susceptible to Staphyloccocus aureus colonization and skin infections.

July 28 is World Hepatitis Day. The organizers of the awareness campaign are using a variety of channels, including social media, to educate and inform patients and clinicians about hepatitis prevention and treatment.

A clinical trial is evaluating the use of the Kokoro app to deliver a smartphone-based CBT program to patients being treated for depression.

Rosacea affects approximately 16 million people in the United States, and patients often present with a variety of symptoms and need an individualized treatment plan.

Trigeminal neuralgia is often mistreated or under-treated. Even when treatment is appropriately delivered, there can be troublesome side effects and complications. Proper diagnosis and treatment typically involves coordination of care among neurologists, anaesthesiologists, dentists, neurosurgeons, and neuroradiologists